We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current BIT market cap is 61.35M. The company's latest EPS is AUD -0.0039 and P/E is -17.95.
Year End 30 June 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
Total Revenue | 1.07M | 803k | 1.46M | 1.56M | 1.43M |
Operating Income | -1.7M | -3.64M | -3.2M | -2.78M | -3.61M |
Net Income | -1.61M | -3.58M | -3.19M | -2.78M | -3.49M |
Year End 30 June 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
Total Assets | 5.86M | 7.83M | 4.33M | 1.91M | 4.14M |
Total Liabilities | 418k | 853k | 464k | 814k | 963k |
Total Equity | 5.44M | 6.97M | 3.86M | 1.09M | 3.17M |
Year End 30 June 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
Operating | -1.5M | -3.08M | -3.41M | -2.44M | -3.29M |
Investing | -53k | N/A | -6k | N/A | N/A |
Financing | 5.75M | 5M | -37k | -33k | 5.53M |
Market Cap | 61.35M |
Price to Earnings Ratio | -17.95 |
Price to Sales Ratio | 43.75 |
Price to Cash Ratio | 15.91 |
Price to Book Ratio | 19.91 |
Dividend Yield | - |
Shares Outstanding | 902.28M |
Average Volume (1 week) | 810.25k |
Average Volume (1 Month) | 4.28M |
52 Week Change | 142.86% |
52 Week High | 0.125 |
52 Week Low | 0.024 |
Spread (Intraday) | 0.01 (6.85%) |
Company Name | Biotron Limited |
Address |
level 2 sydney, new south wales 2000 |
Website | https://www.biotron.com.au |
Industry | diagnostic pharmaceutical (H3) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions